Onconetix vs Shattuck Labs
Shattuck Labs is the larger business, with $1.0m of revenue in fiscal 2025 against $815,371 for Onconetix (1.2 times as much). Onconetix grew faster (-67.7% against -82.5%). Onconetix kept more of each dollar of sales as profit: a net margin of -1721.0% against -4880.9%. Onconetix carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | OnconetixONCO, 2025 | Shattuck LabsSTTK, 2025 |
|---|---|---|
| Revenue | $815,371 | $1.0m |
| Revenue growth | -67.7% | -82.5% |
| Net income | −$14.0m | −$48.8m |
| Operating margin | -2190.0% | -5150.8% |
| Net margin | -1721.0% | -4880.9% |
| Return on equity | -115.5% | -60.3% |
| Free cash flow | −$9.7m | −$40.0m |
| Cash | $5.2m | $54.2m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 40 |
| Market value | $2.0m | $546m |
| Price vs our value range | — | — |
| Moat score | — | 12 (Weak) |
| Insider trades, 12 months | 3 buys, 3 sales | 1 buys, 6 sales |